scispace - formally typeset
J

Jayne S. Danska

Researcher at University of Toronto

Publications -  90
Citations -  7531

Jayne S. Danska is an academic researcher from University of Toronto. The author has contributed to research in topics: T-cell receptor & T cell. The author has an hindex of 38, co-authored 89 publications receiving 6642 citations. Previous affiliations of Jayne S. Danska include Stanford University & Cold Spring Harbor Laboratory.

Papers
More filters
Journal ArticleDOI

Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity

TL;DR: It is demonstrated that early-life microbial exposures determine sex hormone levels and modify progression to autoimmunity in the nonobese diabetic (NOD) mouse model of type 1 diabetes (T1D), and Colonization by commensal microbes elevated serum testosterone and protected NOD males from T1D.
Journal ArticleDOI

Stem cell gene expression programs influence clinical outcome in human leukemia

TL;DR: It is shown that acute myeloid leukemia (AML) follows a CSC model on the basis of sorting multiple populations from each of 16 primary human AML samples and identifying which contain leukemia stem cells (LSCs) using a sensitive xenograft assay, establishing that LSCs are clinically relevant and not artifacts of xenotransplantation.
Journal ArticleDOI

Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.

TL;DR: The ability of rIL-4 to reverse completely the NOD thymic and peripheral T cell proliferative defect in vitro and protect against diabetes in vivo provides further support for a causal relationship between this T cell Proliferative unresponsiveness and susceptibility to diabetes in NOD mice.
Journal ArticleDOI

Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells

TL;DR: It is found that the NOD Sirpa allele conferred support for human hematopoiesis, and Sirpa polymorphism was identified as a potent genetic determinant of the engraftment of human heMatopoietic stem cells.
Journal ArticleDOI

V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors.

TL;DR: It is demonstrated that a p53-mediated DNA damage checkpoint contributes to the immune deficiency characteristic of the scid mutation and limits the oncogenic potential of DSBs generated during V(D)J recombination.